These two players have already demonstrated their AI strengths.

The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to $8.49 billion.

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

Back in January, DeepSeek sparked a frenzy in the tech landscape with its R1 model, and now it has returned to ignite a debate once again. According to the AI startup, it spent $294,000 on training ...

Pentair is only one year away from potentially becoming a Dividend King. The stock's performance has beaten the S&P 500 hands down over the last five years. Pentair could be appealing to investors ...

Generating a 50% return in one year is impressive. Doing it twice is amazing, and it might have you thinking that the stock is due for a letdown. But the stocks listed here are all on track to ...

Stocks wobbled to begin the week but soon regained their footing, with the Dow Jones Industrial Average erasing a modest loss of 279 points to trade on either side of unchanged, while the S&P 500 and ...

The Federal Reserve pays close attention to inflation data when making decisions about monetary policy and where to set interest rates. That means investors often watch the monthly release of the ...

Nov 20 (Reuters) - Most Gulf stock markets ended higher on Thursday, tracking global peers after Nvidia's (NVDA.O), opens new tab strong earnings and upbeat forecast eased concerns about a potential ...

According to Alphabet Chief Executive Sundar Pichai, the fallout in the artificial intelligence boom will spare no one, and that soaring valuations and rising investments have raised serious concerns ...